Deb Godes and Rachel Stauffer join the Breakroom to discuss the newly released FDA proposed rule on laboratory developed tests (LDTs), stakeholder input the agency is seeking and how Congress may react to the rulemaking. For more information on the LDT proposed rule, read our +Insight and Regs&Eggs blog.